Board

UMC has an international Board; WHO and the Swedish Government each appoints three members.

The operations of the UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish Government. The Centre has an international Board; WHO and the Swedish Government each appoints three members.

From 2010 the Chairman of the Board has been Dr Anders Milton, who has held senior positions in many Swedish health-related organisations.

The other members appointed by the Swedish Government are:

Dr Thomas Bradley, Clinical Pharmacologist, Karolinska University Hospital

Dr Filippa Nyberg, Executive Director, Swedish Society of Medicine

Alternates:

Professor Johanna Adami, Principal, Sophiahemmet University

Ms Inger Andersson, various appointments, including former acting Director General at the Medical Products Agency in Sweden

Associate Professor Anders Grahnén, President, Grahnen Consulting AB

WHO has appointed:

Ms Emer Cooke, Head, Regulation of Medicines and other Health Technologies, Essential Medicines and Health Products, World Health Organization

Dr Gayatri Jayaraman, Marketed Health Products Safety and Effectiveness Information Bureau, Canada

Dr Fred Moin Siyoi, CEO, Pharmacy and Poisons Board, Kenya

Alternates:

Dr Shanthi Pal, Group Lead, Medicines Safety, Safety & Vigilance, World Health Organization

Dr Rika Wakao, Review Director, Office of Regulatory Science, Office of Safety II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Mr Mick Foy, Group Manager, MHRA , Vigilance and Risk Management of Medicines 

Last modified on: November 27, 2018
.